Group 1 - The company reported revenue of approximately HKD 95.2 million for the fiscal year ending June 30, 2025, representing a year-on-year increase of about 35.9% [1] - The gross profit margin increased to approximately 38.2%, compared to 29.5% in the fiscal year 2024 [1] - The total profit and comprehensive income for the fiscal year 2025 amounted to approximately HKD 2.3 million, a significant improvement from a loss of approximately HKD 2.3 million in the fiscal year 2024 [1] - Earnings per share attributable to the owners of the company was HKD 0.0144 [1] Group 2 - To expand its business base and enhance stability, the company entered the sales and distribution of food, daily necessities, and public products in March 2021 [1] - In March 2024, the company ventured into the catering business, which is expected to meet daily demand and provide stable cash flow due to consistent market demand [1]

Core Viewpoint - JBB BUILDERS (01903) reported a significant increase in revenue and profitability for the fiscal year ending June 30, 2025, driven by new contracts and completed construction projects [1] Financial Performance - Revenue reached approximately 427 million Malaysian Ringgit, representing a year-on-year growth of about 29.7% [1] - The profit attributable to the company's owners for the year was 1.331 million Malaysian Ringgit, marking a turnaround from a loss to profitability [1] - Basic and diluted earnings per share were 0.27 Malaysian Ringgit [1] Growth Drivers - The substantial revenue increase was primarily due to new contracts awarded for reclamation and related engineering, as well as building and infrastructure services since 2024 [1] - The company completed a higher volume of construction projects during the fiscal year ending June 30, 2025 [1] Offset Factors - The revenue growth was partially offset by several factors, including: - A decline in sand transportation volume from offshore contracts in Singapore [1] - No ship fuel trading activities during the period [1] - Completion of certain contracts in the fiscal year ending June 30, 2024, which had previously contributed to annual revenue [1]

此外，在加速"开源节流"的同时，近年来心玮医疗也在进一步完善自身研产销一体化创新闭环，夯实公 司从"结构铺垫"到"商业兑现"跨越的基础。截至目前，公司共有32款器械产品获NMPA批准，三款器械 产品获 FDA批准及一款产品获得CE标志，产品管线广泛涵盖急性缺血性脑卒中及神经血管狭窄治疗、 缺血性脑卒中预防、出血性脑卒中治疗以及介入通路。 智通财经APP获悉，心玮医疗-B(06609)尾盘涨近7%，截至发稿，涨6.8%，报64.4港元，成交额2505.96 万港元。 消息面上，心玮医疗近日公布中期业绩。上半年公司营业收入达1.86亿元，同比增长44.4%；股东应占 净利润5090万元，同比实现扭亏为盈，已顺利跨越盈亏平衡点。智通财经APP在《新品放量叠加研产销 一体化闭环构筑，心玮医疗-B(06609)迎来"戴维斯双击"》中指出，随着上半年出血性产品开启量化贡 献与缺血性产品矩阵持续迭代，持续完善的通路/止血的"术式闭环"成为心玮医疗上半年收入增量主引 擎。 ...

8月29日，光启科学发布截至2025年6月30日止6个月业绩，该集团期内取得收入3365.6万港元，同比增 加5.08%；公司拥有人应占溢利182.1万港元，同比扭亏为盈。 （原标题：光启科学(00439)股东将股票存入渣打银行(香港) 存仓市值3.21亿港元） 智通财经APP获悉，香港联交所最新资料显示，9月3日，光启科学(00439)股东将股票存入渣打银行(香 港)，存仓市值3.21亿港元，占比29.00%。 ...

Core Viewpoint - The company reported significant growth in its mid-term performance for 2025, driven by new product launches and increased sales in its medical devices for stroke treatment [1] Financial Performance - The company achieved revenue of RMB 186 million, representing a year-on-year increase of 44.4% [1] - Gross profit reached RMB 127 million, up 53.9% year-on-year [1] - Net profit attributable to shareholders was RMB 50.94 million, marking a turnaround from a loss [1] Business Growth Drivers - The improvement in financial performance is primarily attributed to increased revenue from new hemorrhagic stroke treatment devices and rising sales of ischemic stroke treatment devices [1] - Sales of ischemic stroke treatment devices and other related devices increased by 38.3% and 29.2%, respectively [1] - Revenue from hemorrhagic stroke treatment devices increased by approximately RMB 37.7 million compared to the same period in 2024, largely due to the launch of new devices [1] Strategic Focus - The company is continuously upgrading its neurointerventional business to focus on differentiated treatment devices [1]

Core Viewpoint - Corning Pharmaceutical-B (09966) experienced a significant stock price increase of 8.86%, reaching HKD 10.08, with a trading volume of HKD 18.195 million following the release of its interim results for the six months ending June 30, 2025 [1] Financial Performance - The company reported a revenue of RMB 319 million, representing an 84.05% year-on-year increase [1] - The net profit for the period was RMB 21.575 million, a turnaround from a loss of RMB 44.896 million in the same period last year, indicating a successful recovery [1] - Basic earnings per share were reported at RMB 0.02 [1] Research and Development Expenditure - R&D expenses increased from RMB 194.5 million for the six months ending June 30, 2024, to RMB 253.2 million for the current reporting period, an increase of RMB 58.7 million [1] - The rise in R&D spending is attributed to an increase in the number of ongoing clinical trials, expansion of clinical research scale, and progress in clinical trials for candidate drugs [1]

Core Viewpoint - The company, SJM Holdings Limited, reported a significant increase in net revenue and a return to profitability for the six months ending June 30, 2025, driven by improved performance in its gaming and non-gaming operations [1] Financial Performance - For the six months ending June 30, 2025, the company achieved net revenue of HKD 19.965 billion, representing a year-on-year increase of 12.38% [1] - The profit attributable to shareholders was HKD 351 million, marking a return to profitability compared to the previous period [1] - Basic earnings per share were HKD 0.18 [1] Operational Insights - The improvement in profitability was primarily attributed to enhanced performance in the gaming and hotel operations, although increased business activity led to a rise in operating costs, partially offsetting the gains [1] - The company recognized an impairment of HKD 27.3 million related to the Mocha Clubs, which are set to cease operations by the end of 2025 [1] - Additionally, an impairment of HKD 5 million was recorded for certain properties, plants, and equipment due to the lack of improvement in the performance of the new SJM property [1]

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [2] Core Views - The company achieved a revenue of 3.717 billion yuan in the first half of 2025, representing a year-on-year increase of 66.49%, and turned a profit with a net profit of 181 million yuan [8] - The company continues to experience a decline in breeding costs while achieving rapid growth in scale, with a pig output of 1.9096 million heads in the first half of 2025, up 74.47% year-on-year [8] - The company is expected to achieve revenues of 6.3 billion yuan, 7.8 billion yuan, and 8.5 billion yuan from 2025 to 2027, with corresponding net profits of 467 million yuan, 986 million yuan, and 1.171 billion yuan [8] Financial Performance - The company's revenue for 2023 is projected at 4.041 billion yuan, with a growth rate of 1.8%, and is expected to reach 6.078 billion yuan in 2024, reflecting a growth rate of 50.4% [6][9] - The net profit for 2023 is forecasted to be -645 million yuan, turning positive in 2024 with a net profit of 519 million yuan [6][9] - The earnings per share (EPS) is expected to improve from -1.28 yuan in 2023 to 2.30 yuan by 2027 [6][9] Cost Management - The company maintains industry-leading cost control capabilities, with breeding costs continuing to decline, estimated at approximately 13.4 yuan/kg and 13.2 yuan/kg for Q1 and Q2 of 2025 respectively [8] - The company has successfully integrated quality production capacity resources and improved capacity utilization, leading to significant growth in pig production [8] Cash Flow and Financial Health - As of the first half of 2025, the company reported a net cash flow from operating activities of 602 million yuan, indicating a strong cash position [8] - The company's monetary funds increased by 16.15% compared to the beginning of the year, reaching 670 million yuan [8]

经济观察网 8月29日，百济神州(688235.SH)发布2025年半年度报告，报告期内，公司实现营业收入 175.18亿元，同比增长46.03%。实现归属于上市公司股东的净利润4.5亿元。实现归属于上市公司股东 的扣除非经常性损益的净利润2.61亿元。基本每股收益0.32元。 ...

Core Viewpoint - ZhiJing International Finance (08340) reported a significant increase in revenue and profitability for the six months ending June 30, 2025, indicating strong financial performance and recovery from previous losses [1] Financial Performance - The company achieved a revenue of HKD 40.87 million, representing a year-on-year increase of 96.58% [1] - The profit attributable to the owners of the company was HKD 5.815 million, marking a turnaround from a loss to profitability [1] - Basic earnings per share were reported at HKD 0.105 [1]